MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
about
shRNA interference for extracellular signal-regulated kinase 2 can inhibit the growth of esophageal cancer cell line Eca109.Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathwayMetformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells.Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.Increasing 3D Matrix Rigidity Strengthens Proliferation and Spheroid Development of Human Liver Cells in a Constant Growth Factor Environment.MEK drives cyclin D1 hyperelevation during geroconversionRNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cellsMethoxetamine affects brain processing involved in emotional response in rats.Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2.
P2860
Q33563109-77A60619-7248-4AD1-9C87-DCA7C6BCB3D5Q33938310-7E1E3F80-088C-480A-8663-24212EACC522Q34621046-E14169AD-1AC8-49B7-B291-6D86FEC99DF8Q34988660-ADEAA84E-DF52-410A-B16C-6B5D9EEB3D77Q36099266-0C5AC389-9E1B-4760-9D7C-4A1BB6EED308Q36362544-370254DD-2AA5-4855-8F2E-DC5F369198A7Q37383705-716AEB89-FE15-420C-86F0-CFC960BD2EACQ38709514-2709AA6C-FF87-4FD6-A916-9CA60FAC18E0Q38838612-3DE30259-F177-41BF-8600-C43DA86D54A9Q39126097-79525093-BBEF-46F5-BF7B-5F550E1E8617Q39975996-BB214A43-947E-4E8C-9E2C-CF7A08F12824Q39988571-564EDB35-ED5A-48F8-B1F8-B3E11ED18FFFQ47777693-10FDDDDD-2F7C-4B19-8D63-6CF99E2EFFF5Q54770022-FD5E2185-FCD5-435D-9F0B-3D1CA2A196DE
P2860
MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
MEK/ERK-dependent uPAR express ...... n human hepatocarcinoma cells.
@en
type
label
MEK/ERK-dependent uPAR express ...... n human hepatocarcinoma cells.
@en
prefLabel
MEK/ERK-dependent uPAR express ...... n human hepatocarcinoma cells.
@en
P2093
P2860
P356
P1476
MEK/ERK-dependent uPAR express ...... n human hepatocarcinoma cells.
@en
P2093
Alexandre Coutant
Anne Bessard
Christophe Frémin
Frédéric Ezan
Georges Baffet
P2860
P304
P356
10.1002/JCP.21049
P577
2007-08-01T00:00:00Z